Safety and effectiveness of vitamin D mega-dose: A systematic review.
Study Goal
The researchers aimed to review the safety and efficacy of vitamin D mega-dose therapy in normalizing serum vitamin D levels and assessing adverse effects.
Results Summary
The study found that vitamin D mega-dose therapy effectively normalized serum vitamin D levels in 70-100% of patients, with adverse effects ranging from 1.9-18.5%, primarily hypercalcemia/hypercalciuria, but no significant clinical toxicity.
Population
Patients with rickets, osteoporosis, and critically ill patients.
Effective Dosage
Mega-dose (exact dosage not specified in abstract).
Duration
Short periods (exact duration not specified in abstract).
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D mega-dose therapy | increase | serum vitamin levels | - | - | is effective in normalizing | #1 |
vitamin D mega-dose therapy | no change | adverse effects | - | low | toxicity assessed through adverse effects was low | #2 |
vitamin D mega-dose | increase | serum vitamin D levels | patients | between 70 and 100% of patients | normalized | #3 |
vitamin D mega-dose | increase | adverse effects | - | between 1.9 and 18.5% | adverse effects ranged | #4 |
INTRODUCTION: Supplementation with high doses of vitamin D, known as mega-dose or "stoss therapy," refers to administering high doses of vitamin D by oral or intramuscular route in short periods of time. In this sense, conducting a review to organize this knowledge in a single article will generate a helpful instrument for researchers working in this area and for health professionals who use this therapeutic tool. OBJECTIVE: To carry out a literature review on safety and efficacy (normalization of serum vitamin D level, and changes in the clinical picture) of vitamin D mega-dose use. METHODOLOGY: This is a systematic review of the literature searching data through the electronic banks of PubMed, Scielo, and LILACS, using the following keywords: "vitamin D," "mega-dose," "stoss therapy," "cholecalciferol," in different combinations. CONSORT questionnaire was used to assess the quality of the included studies. RESULTS: Of the 59 articles screened for this review, 10 were included in the review, studying patients with rickets, osteoporosis, and critically ill patients. Two studies compared the exact dosage of vitamin D by different routes of administration, and three studies compared different doses by the same route. All others studied vitamin D mega-dose versus placebo. Adverse effects were observed through the presence of hypercalcemia/hypercalciuria. Serum vitamin D levels were normalized between 70 and 100% of patients, and adverse effects ranged between 1.9 and 18.5%. CONCLUSION: The study demonstrated that vitamin D mega-dose therapy is effective in normalizing serum vitamin levels, and the toxicity assessed through adverse effects was low, with no expressive clinical significance. Despite this, there is still a need for further studies in the area to confirm the results found.